|

Advanced Diffusion Imaging in Renal Cancer Patients

RECRUITINGN/ASponsored by NYU Langone Health
Actively Recruiting
PhaseN/A
SponsorNYU Langone Health
Started2022-12-01
Est. completion2028-12-01
Eligibility
Age21 Years – 85 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06116253

Summary

The objective of this study is to apply advanced diffusion imaging in a two-pronged assessment of renal mass patients: (1) characterization of lesion malignancy and subtype, and (2) prediction of renal function stability or decline following partial nephrectomy.

Eligibility

Age: 21 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria:

* Renal mass patients scheduled for laparoscopic partial nephrectomy.
* eGFR above 30 ml/min/m2.
* Ages 21 to 85
* Must be willing and able to provide consent.

Exclusion Criteria:

* All metal implants and dental implants that have ferromagnetic properties and are unsafe at 3.0 T.
* Pregnant women are not eligible for participating in this study.
* Acute claustrophobia

Conditions2

CancerRenal Cancer

Locations1 site

NYU Langone Health
New York, New York, 10016
Malika Kumbella646-501-0075Malika.kumbella@nyulangone.org

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.